Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 81-100 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 81 | Atomic-6 lowweak | Opp 4 Risk 5 | Thesis: Atomic-6 appears to have meaningful strategic upside because the membership rationale says it launched an orbital data center service and has DoD and U.S. Space Force contracts, which would support a long-duration defense/space infrastructure thesis if confirmed. Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited. Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low. |
| 82 | Beijing Guodian High-Tech Technology Co lowweak | Opp 4 Risk 2 | Thesis: Reviewed evidence rationale says the company received approval for a commercial satellite IoT pilot program using the Tianqi constellation of 41 satellites. Regulatory or pilot approval tied to an existing constellation is a meaningful long-horizon opportunity signal if execution follows. Why now: The implied catalyst is the pilot-program approval, but the reviewed sources provide no retained article summary or timestamped evidence row beyond the membership rationale. Caveats: Phase2 membership rationale references: but the actual summary/evidence are absent. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score is restrained because approval alone is described in rationale but not directly evidenced here. |
| 83 | D-Orbit lowweak | Opp 4 Risk 3 | Thesis: Moderate evidence-ranked opportunity: the reviewed sources membership rationale says D-Orbit partnered with Magdrive for an electric propulsion demo and places the company in satellite propulsion/orbital logistics, which suggests active technology development aligned with durable LEO and sustainability themes over a 1 year+ horizon. Why now: Why now is the partnership/demo claim referenced in article ID, but the reviewed sources includes neither nor explicit article timing beyond the article ID prefix, limiting recency precision. Caveats: Opportunity rests on membership rationale rather than fully available direct evidence. Referenced article ID has no in the reviewed sources. Demo activity is not the same as proven commercial traction. |
| 84 | Dhruva Space lowweak | Opp 4 Risk 2 | Thesis: Among this screen, Dhruva Space has one of the stronger reviewed sources rationales: it is described as having received a government grant for Project Garud, a 500 kg-class satellite platform for constellation-scale missions, and later partnering with ICEYE on satellite systems and Earth observation services. If current, those items imply platform and partnership traction that could matter over a 1 year+ horizon. Why now: The reviewed sources references: and: in the membership rationale, suggesting relatively recent strategic developments, but the coverage report still shows zero evidence after recent evidence window, so timing confidence is limited. Caveats: Positive thesis relies on membership rationale, not available direct evidence. Partnership evidence cannot be expanded through relation propagation beyond what is explicitly stated. |
| 85 | EDGX lowweak | Opp 4 Risk 3 | Thesis: Reviewed evidence rationale indicates EDGX is a Belgian spacetech startup with a prior €2.3M seed round and an in-orbit demonstration of its STERNA AI computing system on SpaceX Transporter-16. If still current, in-orbit validation plus prior funding can support a longer-horizon commercialization opportunity. Why now: The membership support references articles, and, implying a narrative of funding plus orbital demonstration, but active evidence remains empty after recent evidence filtering, limiting recency confidence. Caveats: In-orbit demo claim appears only in reviewed sources rationale, not available direct evidence. No evidence confirms whether the prior seed round falls within the current decision horizon relevance. No direct adverse evidence is present, but that is not proof of low fundamental risk. |
| 86 | Ellipsis Drive lowweak | Opp 4 Risk 3 | Thesis: Moderate opportunity on sparse evidence: the reviewed sources membership rationale describes Ellipsis Drive as addressing an Earth observation satellite-data processing bottleneck, with support from space agencies and target users including Earth observation firms. If accurate, that points to a software-layer position that could benefit over a 1 year+ adoption cycle. Why now: Why now is the reviewed sources' claim that the company addresses a key EO data-processing bottleneck and has space-agency support, referenced to article ID: though no or timestamp detail was provided. Caveats: Claims come from membership rationale rather than direct evidence. Referenced article ID: lacks a reviewed sources. Support from agencies and target users is weaker than demonstrated contracted revenue. |
| 87 | Eta Space lowweak | Opp 4 Risk 2 | Thesis: Eta Space has reviewed sources support that its LOXSAT mission will demonstrate 11 cryogenic fluid management technologies in space and that the mission is launched by Rocket Lab for NASA, indicating real technology validation relevance for in-space fueling or orbital servicing over a 1 year+ horizon. Why now: The membership rationale specifically points to the LOXSAT mission demonstration as the current relevance driver, citing article: but the reviewed sources does not include the article or more detailed dated evidence fields. Caveats: Underlying article is not provided in the reviewed sources. Score is based on membership rationale summary rather than available direct evidence. Single-mission validation is weaker than broad commercial traction. |
| 88 | Firefly Aerospace lowweak | Opp 4 Risk 2 | Thesis: Firefly has a positive long-horizon lunar infrastructure angle because recent article context says NASA awarded it a Moon Base contract for MoonFall, a 2028 mission to transport four drones for Artemis-site surveying. Why now: A dated May 26, 2026 article puts a fresh NASA program win into the current evidence window, which can matter over a 1 year+ horizon even if revenue realization is later. Evidence
Caveats: Only one within the recent evidence window article is available. Evidence is supporting article context rather than stronger extracted direct events. Timing of mission realization is long-dated relative to the evidence window. |
| 89 | Hispasat lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources membership rationale states Hispasat is part of the IRIS2 project and will manage the LEO shell. If current, that implies meaningful strategic positioning in a long-duration European satcom infrastructure program. Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain. Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete. |
| 90 | Impulse Space lowweak | Opp 4 Risk 4 | Thesis: Membership rationale ties Impulse Space to a Pentagon deal for space-based interceptor prototypes and identifies orbital transfer vehicle relevance, which would be strategically meaningful over a 1 year+ horizon if confirmed with current evidence, but the reviewed sources does not load the underlying evidence or article summaries after recent evidence window, unavailable in reviewed sources). Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking. Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence. |
| 91 | MDA Space Ltd. lowweak | Opp 4 Risk 3 | Thesis: MDA Space shows some opportunity context from being identified as operating in in-orbit servicing and from an article saying it won a Radarsat replenishment satellite contract, which could support durable government-space demand if current. Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain Evidence
Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either. |
| 92 | Modul8 lowweak | Opp 4 Risk 3 | Thesis: Reviewed evidence membership rationale says Modul8 is a spun-out space communications unit with $40m funding, lunar cellular network deployment, and Artemis spacesuit communications work. If still current, that is among the stronger long-horizon strategic opportunity setups in this screen, but the reviewed sources does not provide citeable direct evidence or article. Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence. Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk. |
| 93 | Momentus Inc lowweak | Opp 4 Risk 5 | Thesis: Membership rationale says Momentus secured a new commercial contract for its Vigoride-9 orbital service vehicle and identifies the company as an orbital service vehicle / orbital services platform business, which would support a real opportunity thesis for space logistics if current and corroborated. However, these reviewed sources have no direct evidence or article summaries after recent evidence window, so the opportunity score must stay modest (: and: unavailable in reviewed sources). Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence. Caveats: No direct evidence remained after the recent evidence filter. |
| 94 | NEC Corporation lowweak | Opp 4 Risk 2 | Thesis: Membership rationale states NEC launched an Orbital Transfer Vehicle development project selected by JAXA and aims for Asia's first OTV deployment. That would be a credible long-horizon strategic opportunity if current, but the reviewed sources provide no available direct evidence or article summaries inside the recent evidence window to validate progress (: unavailable in reviewed sources). Why now: Why now is medium rather than weak because an OTV development project can be durable over 1 year+, but evidentiary support in the reviewed sources are thin after recent evidence window. Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Current milestone timing is unverified in the reviewed sources. |
| 95 | NewOrbit Space mediummedium | Opp 4 Risk 4 | Thesis: NewOrbit Space has a plausible long-horizon opportunity because an article says it is developing satellites for very low Earth orbit and raised $18.5 million in a Series A round, suggesting both a differentiated technical focus and capital to pursue it. Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated Evidence
Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation. |
| 96 | NorthStar Earth & Space lowweak | Opp 4 Risk 3 | Thesis: NorthStar Earth & Space appears strategically relevant to space domain awareness and may have public-market access or financing optionality via a SPAC path, but these reviewed sources provide only limited supporting article context and no strong in-window direct facts for business traction. Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here. Evidence
Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale. |
| 97 | Obruta Space Solutions lowweak | Opp 4 Risk 4 | Thesis: Obruta operates in a strategically attractive area: autonomous docking for on-orbit servicing and logistics, with stated use cases including inspection, orbital refueling, satellite life extension, debris removal, and orbital logistics. That gives a plausible long-horizon opportunity narrative if product or customer validation emerges. Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year. Evidence
Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown. |
| 98 | Observable Space lowweak | Opp 4 Risk 4 | Thesis: Moderate opportunity based on the reviewed sources membership rationale that Observable Space was listed among notable space startup funding deals at $90 million. A funding round of that size can support growth over a 1 year+ horizon if deployed effectively. Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence. Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without. |
| 99 | OMSPACE lowweak | Opp 4 Risk 4 | Thesis: The reviewed sources membership rationale says OMSPACE successfully launched a sounding rocket and plans an orbital launch vehicle by 2027 for small satellites. That suggests a real technical progression path if the company can convert suborbital progress into orbital capability over the next year-plus. Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment. Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced. |
| 100 | Orbital lowweak | Opp 4 Risk 3 | Thesis: Orbital has modest evidence-backed opportunity because a dated within the recent evidence window article says it raised $5 million to fund an in-orbit computing demonstration next year and support initial work on its first purpose-built orbital compute satellite, Orbital-1, slated for 2028, indicating financing plus roadmap progress relevant to a 1 year+ horizon, June 10, 2026). Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones. Evidence
Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows. |
Risk view
Showing rows 181-200 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 181 | MizarVision lowweak | Opp 1 Risk 2 | Thesis: The same geopolitical context that implies imagery relevance also raises some reputational/regulatory uncertainty, but the reviewed sources does not provide direct negative evidence. Risk is slightly elevated only because the evidence context is indirect and sensitive rather than commercially validating. Why now: No in-recent evidence window article summary or evidence row is available for MizarVision. The only timing cue is an uncited phase2 rationale referencing article id without. Caveats: Evidence is indirect and not strongly company-specific according to the reviewed sources rationale. No citable article or summary is provided for the referenced article id. No evidence were available after recent evidence window. |
| 182 | Moog Inc. lowweak | Opp 1 Risk 2 | Thesis: A slight risk score above the minimum is warranted because the phase-2 rationale references a lawsuit context involving Moog Space tied to article, but the reviewed sources provide no or retained details, so this cannot support a stronger negative thesis. Why now: Why now is weak because the reviewed sources have no within the recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0. Caveats: The lawsuit reference exists only in phase-2 rationale without or retained evidence detail, so it is too weak for a material risk call. No direct evidence arrays are populated. Score reflects limited unresolved risk context plus very sparse evidence. |
| 183 | Moonshot Space lowweak | Opp 1 Risk 2 | Thesis: The concept appears early-stage from the membership rationale, and without retained post-recent evidence window evidence, development, technical, and funding-continuity risk dominate the current evidence picture. Why now: There is no strong why-now signal because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window; the cited support article is referenced only in membership rationale without a in the reviewed sources. Caveats: No article is provided for membership support article, so the underlying factual statements cannot be elevated beyond low-confidence context. No direct positive or direct negative evidence are available after recent evidence window. Long-horizon potential exists, but current reviewed sources support is too thin for a stronger score. |
| 184 | Motiv Space Systems lowweak | Opp 2 Risk 2 | Thesis: Risk is mostly uncertainty risk: the reviewed sources does not provide material adverse evidence, but it also lacks recent dated company-specific proof of traction, making the business outlook hard to assess. Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied. Evidence
Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources. |
| 185 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: Risk is modestly elevated only because the reviewed sources frames Mynaric as a component supplier with classification ambiguity and no surviving fresh evidence; there is still no direct adverse evidence cited within the recent evidence window. Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here. Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps. |
| 186 | Mynaric AG lowweak | Opp 2 Risk 2 | Thesis: Ownership/status transition risk may matter because the reviewed sources describes Mynaric as acquired, but chronology, terms, and current status are not citable from the provided data, and no adverse evidence survive recent evidence window. Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only. |
| 187 | N SPACE TECH lowweak | Opp 2 Risk 2 | Thesis: Risk is chiefly lack of validated current progress: no retained evidence establishes recent funding, contracts, launches, or customer deployments. Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference. Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity. |
| 188 | NEC Corporation lowweak | Opp 4 Risk 2 | Thesis: No direct negative evidence is present, and NEC's risk score is kept relatively low because the reviewed sources does not show material adverse events; the main issue is simply lack of available current proof of execution or commercialization (: unavailable in reviewed sources). Why now: Why now is medium rather than weak because an OTV development project can be durable over 1 year+, but evidentiary support in the reviewed sources are thin after recent evidence window. Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Current milestone timing is unverified in the reviewed sources. |
| 189 | Neo Space Group lowweak | Opp 1 Risk 2 | Thesis: Main risk is lack of validated current evidence: the reviewed sources only indicates counterparty/customer context and does not directly establish Neo Space Group's own operating role or near-term business momentum. Why now: No validated near-term or durable timing signal is available in the available evidence. Recency is uncertain because zero after-recent evidence window evidence were available. Caveats: Phase-2 rationale references, but no or summary is provided in the reviewed sources. Counterparty context should not be treated as propagated evidence for Neo Space Group's own thesis. Coverage debug shows zero evidence after recent evidence window. |
| 190 | Northwood Space mediumweak | Opp 5 Risk 2 | Thesis: The reviewed sources provide no material adverse evidence; main risk is that the evidence base is thin and concentrated in a single cited article rather than multiple corroborated events. Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources. Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction. |
| 191 | OHB SE lowweak | Opp 2 Risk 2 | Thesis: Current reviewed sources risk is uncertainty: no retained evidence confirms current orders, program milestones, or problems, leaving both upside and downside weakly evidenced. Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state. Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view. |
| 192 | Optera lowweak | Opp 2 Risk 2 | Thesis: There is no direct negative evidence, but coverage is too thin to establish either durable upside or a specific adverse thesis. Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources. Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own. |
| 193 | Orbit Fab lowweak | Opp 3 Risk 2 | Thesis: The main risk is evidentiary and timing uncertainty: the most substantive operational claims are stale relative to the recent evidence window, while retained evidence is undated supporting article context rather than company-specific current contracts, customers, or financing. Why now: Why now is only moderate because retained evidence after filtering consists of undated context from Space Index, not a dated current catalyst; the older company-site article from December 24, 2022 may indicate strategic readiness, but recency is weak Evidence
Caveats: Retained evidence is weak context and supporting article context, not direct event/fact evidence. The more detailed article is dated December 24, 2022 and was dropped by the 90-day recent evidence window; it should not be treated as current proof. The undated Space Index row is relevance context only and not recency proof. |
| 194 | OrbitAID Aerospace lowweak | Opp 3 Risk 2 | Thesis: The main risk is execution and evidence scarcity: the reviewed sources show product claims but no dated commercial traction, contracts, or deployment proof within the recent evidence window. That is a real uncertainty, but not strong adverse evidence. Why now: Why now is weak because the surviving evidence is undated company-context material rather than a fresh milestone. Recency-sensitive claims are uncertain Evidence
Caveats: Evidence kept after recent evidence window is undated and marked context, not recency proof. No direct positive event, contract, financing, or customer traction is available. Same-article repeated rows are not independent confirmation. |
| 195 | Orbital lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources also states that Orbital does not clearly fit the named cohort categories, and no direct company-specific positive or negative evidence survive the recent evidence window in these reviewed sources. That makes the thesis speculative and category fit uncertain. Why now: The only reason to rank it slightly above peers is the reviewed sources' description of funding plus a planned LEO satellite, which is at least directionally aligned with a 1 year+ horizon. But there is no retained dated evidence to verify recency, sequencing, or milestone timing. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The positive view comes from phase2 rationale text rather than available direct event/facts. |
| 196 | Orbitworks lowweak | Opp 4 Risk 2 | Thesis: Execution risk is implicitly elevated because the rationale references a planned constellation and program participation rather than delivered operating results, but no direct adverse evidence is available. Why now: The rationale references growth-oriented planned activity, which is relevant to a 1 year+ horizon, yet timing confidence is limited because coverage data shows no evidence after recent evidence window. Caveats: Membership rationale references article IDs, and: but and article summaries are not provided in the reviewed sources. No direct positive_evidence or negative_evidence arrays are populated. Opportunity is based on stated plans, not validated conversion, contracts, or operating milestones inside the recent evidence window. |
| 197 | Orion Space Solutions mediummedium | Opp 5 Risk 2 | Thesis: Opportunity evidence is weakened by the fact that the key support is supporting article context rather than stronger structured company-event evidence, and the customer is undisclosed. Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon Evidence
Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation. |
| 198 | OroraTech mediummedium | Opp 5 Risk 2 | Thesis: The main risk is evidence quality rather than identified business distress: the reviewed sources provide only supporting article context and no direct positive events or direct adverse rows, so thesis strength is limited and durability of traction beyond this deployment is uncertain. Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists Evidence
Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk. |
| 199 | Paladin Space lowweak | Opp 2 Risk 2 | Thesis: Risk is mostly lack of validation and scale uncertainty because there is only a one-article universe and zero available evidence after recent evidence window. Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress. Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence. |
| 200 | Palantir Technologies lowweak | Opp 1 Risk 2 | Thesis: Risk is low-to-moderate only because evidence support is missing; the reviewed sources contain no direct adverse evidence, but it also does not provide ranking-grade proof of space-specific upside in the recent evidence window. Why now: Why now is weak because the reviewed sources references article IDs, and in the membership rationale, but no or reviewed evidence are provided for ranking use. Caveats: High mention count is not conviction. Cohort relevance via Space Force context is not enough without direct event/fact evidence. Coverage debug shows zero evidence after recent evidence window despite large article universe. |